AMG 531 Treatment of Thrombocytopenic Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Prior to Splenectomy

This study has been completed.

Study NCT00102336 Information provided by Amgen

First Received: January 27, 2005 Last Updated: May 7, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Study Completion Date:	April 2007
Primary Completion Date:	December 2006 (Final data collection date for primary outcome measure)